Today: 19 June 2026

Nvidia, Broadcom, Applied Materials, Intel, Oracle lead AI infrastructure stocks

Nvidia, Broadcom, Applied Materials, Intel, Oracle lead AI infrastructure stocks

Nvidia tops the new AI infrastructure buy list as it expands beyond chips, joining a $10 billion Helix Digital Infrastructure launch; Broadcom surges with a $35 billion AI XPV Platform, Applied Materials wins analyst upgrades after Singapore expansion, Intel gets a BofA upgrade on AI CPU demand, while Oracle faces funding risks after a sharp post-earnings selloff despite record cloud growth. (Reuters)
Dow surges almost 930 points after the bell as oil drops on Iran strike reversal

Dow surges almost 930 points after the bell as oil drops on Iran strike reversal

Dow surges 1.86% to 50,848.38 as oil prices plunge after President Trump cancels planned strikes on Iran, easing geopolitical fears; Honeywell, Boeing, Caterpillar, Nike, and Amgen lead gains, while Chevron and Microsoft lag; Brent crude drops 3.93% to $89.44, but inflation concerns persist with May PPI up 1.1% and final demand prices up 6.5% year-over-year.
VOYG jumps after BTIG buy call, SpaceX IPO talk heats up

VOYG jumps after BTIG buy call, SpaceX IPO talk heats up

Voyager Technologies soared 17% to $48.26 after BTIG initiated coverage with a Buy rating and $55 price target, fueling a rally amid surging investor interest in space and defense stocks ahead of SpaceX’s IPO; VOYG’s gains outpaced the broader market as analysts cited its acquisition-driven growth and rising backlog, while the stock traded above consensus targets and below its 52-week high.
MARA Stock Edges Higher After Bitcoin Holds Steady, Q1 Miss and AI Uncertainty in Focus

MARA Stock Edges Higher After Bitcoin Holds Steady, Q1 Miss and AI Uncertainty in Focus

MARA surged 5.2% to $13.27 as bitcoin rebounded to $63,375, drawing investor focus after a sharp prior-session drop, even as Q1 net loss widened to $1.26 billion on lower revenue and bitcoin sales; the stock’s move reflects renewed risk appetite amid ongoing concerns over financial performance and the company’s pivot toward AI and data center infrastructure.
1 29 30 31 32 33 2,082

Stock Market Today

  • Bitcoin Traders Increase Bearish Bets as Price Slides to $52,000
    June 19, 2026, 4:04 AM EDT. Bitcoin faces pressure as traders increase bearish bets amid a hawkish U.S. Federal Reserve that strengthens the dollar. Bitcoin exchange-traded funds (ETFs) are experiencing continuous outflows, while Strategy, the largest publicly listed bitcoin holder, confronts challenges with its preferred stock STRC plunging below $100 par value. This decline undermines Strategy's bitcoin accumulation plan. Arca CIO Jeff Dorman warns Strategy must sell bitcoin (BTC) and MicroStrategy (MSTR) shares to stabilize STRC or risk further capital structure erosion. BTC prices hovered near $62,400, down 0.8% from midnight UTC, after reaching $67,000 earlier this week, reflecting heightened market uncertainty.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 19.06.2026

19 June 2026
LIVEMarkets rolling coverageStarted: June 19, 2026, 4:00 AM EDTUpdated: June 19, 2026, 4:08 AM EDT Bitcoin Traders Increase Bearish Bets as Price Slides to $52,000 June 19, 2026, 4:04 AM EDT. Bitcoin faces pressure as traders increase bearish bets amid a hawkish U.S. Federal Reserve that strengthens the dollar. Bitcoin exchange-traded funds (ETFs) are experiencing continuous outflows, while Strategy, the largest publicly listed bitcoin holder, confronts challenges with its preferred stock STRC plunging below $100 par value. This decline undermines Strategy’s bitcoin accumulation plan. Arca CIO Jeff Dorman warns Strategy must sell bitcoin (BTC) and MicroStrategy (MSTR) shares to stabilize
Kardigan pops in first Nasdaq trading after $400 million IPO

Kardigan pops in first Nasdaq trading after $400 million IPO

19 June 2026
Kardigan surged 37.5% above its $16 IPO price to close at $22 after raising $400 million in an upsized Nasdaq debut, signaling renewed investor appetite for large biotech IPOs as the company advances three late-stage cardiovascular drug candidates.
Go toTop